Literature DB >> 8384185

Clinical aspects of ephedrine in the treatment of obesity.

R Pasquali1, F Casimirri.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8384185

Source DB:  PubMed          Journal:  Int J Obes Relat Metab Disord


× No keyword cloud information.
  4 in total

Review 1.  Pharmacological approaches for the treatment of obesity.

Authors:  José-Antonio Fernández-López; Xavier Remesar; Màrius Foz; Marià Alemany
Journal:  Drugs       Date:  2002       Impact factor: 9.546

Review 2.  Drug therapy for obesity in the elderly.

Authors:  R Dvorak; R D Starling; J Callés-Escandon; E A Sims; E T Poehlman
Journal:  Drugs Aging       Date:  1997-11       Impact factor: 3.923

3.  Muscle uncoupling protein 3 expression is unchanged by chronic ephedrine/caffeine treatment: results of a double blind, randomised clinical trial in morbidly obese females.

Authors:  Renata Bracale; Maria Letizia Petroni; Sergio Davinelli; Umberto Bracale; Giovanni Scapagnini; Michele O Carruba; Enzo Nisoli
Journal:  PLoS One       Date:  2014-06-06       Impact factor: 3.240

4.  Comparative evaluation of flavone from Mucuna pruriens and coumarin from Ionidium suffruticosum for hypolipidemic activity in rats fed with high fat diet.

Authors:  Satheesh Kumar Dharmarajan; Kottai Muthu Arumugam
Journal:  Lipids Health Dis       Date:  2012-10-02       Impact factor: 3.876
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.